Health
New listings – Australian Journal of Pharmacy
The Health Minister has highlighted new PBS listings from Monday, March 1, including drugs to treat MS, asthma and diabetes From March 1, Zeposia and Atecture Breezhaler…
From March 1, Zeposia and Atecture Breezhaler will be listed on the PBS for the first time, and Trulicity will have its PBS listing extended, Greg Hunt said.
Zeposia (ozanimod) is used to treat relapsing remitting multiple sclerosis (RRMS), a chronic disease that attacks the central nervous system, and for which a cure is yet to be found, the Minister said in a statement.
Over 25,600 people in Australia have multiple sclerosis, and it affects each person differently, with more than 10 Australians…
-
Business22 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
General22 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Noosa News8 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
General22 hours agoTaiwan’s President Lai Ching-te calls for peace and dialogue with China while also calling for defence boosts